After Theranos, Healthcare Startups Still Aren’t Publishing Enough Peer-Reviewed Research, Says One Stanford Professor. Venture Capitalists Disagree.

Healthcare startups are conducting “stealth research” without publishing papers in journals for scientists to read and evaluate their marketing claims, a team of Stanford researchers says. Venture capitalists in the space argue that the research is flawed, and that startups, especially those developing new drugs or medical devices, face scrutiny of their work in many other ways.